Cargando…
Diabetic Nephropathy: Novel Molecular Mechanisms and Therapeutic Targets
Diabetic nephropathy (DN) is one of the major microvascular complications of diabetes mellitus and the leading cause of end-stage kidney disease. The standard treatments for diabetic patients are glucose and blood pressure control, lipid lowering, and renin-angiotensin system blockade; however, thes...
Autores principales: | Zoja, Carlamaria, Xinaris, Christodoulos, Macconi, Daniela |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7845653/ https://www.ncbi.nlm.nih.gov/pubmed/33519447 http://dx.doi.org/10.3389/fphar.2020.586892 |
Ejemplares similares
-
Endothelial Glycocalyx of Peritubular Capillaries in Experimental Diabetic Nephropathy: A Target of ACE Inhibitor-Induced Kidney Microvascular Protection
por: Locatelli, Monica, et al.
Publicado: (2023) -
MicroRNA-184 is a downstream effector of albuminuria driving renal fibrosis in rats with diabetic nephropathy
por: Zanchi, Cristina, et al.
Publicado: (2017) -
Thyroid hormone treatment counteracts cellular phenotypical remodeling in diabetic organs
por: Lavecchia, Angelo M., et al.
Publicado: (2023) -
Sirtuin 3 Deficiency Aggravates Kidney Disease in Response to High-Fat Diet through Lipotoxicity-Induced Mitochondrial Damage
por: Locatelli, Monica, et al.
Publicado: (2022) -
Renal Primordia Activate Kidney Regenerative Events in a Rat Model of Progressive Renal Disease
por: Imberti, Barbara, et al.
Publicado: (2015)